These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20530687)

  • 1. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
    Rausch V; Liu L; Kallifatidis G; Baumann B; Mattern J; Gladkich J; Wirth T; Schemmer P; Büchler MW; Zöller M; Salnikov AV; Herr I
    Cancer Res; 2010 Jun; 70(12):5004-13. PubMed ID: 20530687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.
    Kallifatidis G; Labsch S; Rausch V; Mattern J; Gladkich J; Moldenhauer G; Büchler MW; Salnikov AV; Herr I
    Mol Ther; 2011 Jan; 19(1):188-95. PubMed ID: 20940707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
    Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
    Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary polyphenol quercetin targets pancreatic cancer stem cells.
    Zhou W; Kallifatidis G; Baumann B; Rausch V; Mattern J; Gladkich J; Giese N; Moldenhauer G; Wirth T; Büchler MW; Salnikov AV; Herr I
    Int J Oncol; 2010 Sep; 37(3):551-61. PubMed ID: 20664924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells.
    Ulivi P; Arienti C; Zoli W; Scarsella M; Carloni S; Fabbri F; Tesei A; Chiadini E; Orlandi A; Passeri D; Zupi G; Milandri C; Silvestrini R; Amadori D; Leonetti C
    Curr Cancer Drug Targets; 2010 Sep; 10(6):600-10. PubMed ID: 20491617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line.
    Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y
    Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.
    Labsch S; Liu L; Bauer N; Zhang Y; Aleksandrowicz E; Gladkich J; Schönsiegel F; Herr I
    Int J Oncol; 2014 May; 44(5):1470-80. PubMed ID: 24626333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.
    Kallifatidis G; Rausch V; Baumann B; Apel A; Beckermann BM; Groth A; Mattern J; Li Z; Kolb A; Moldenhauer G; Altevogt P; Wirth T; Werner J; Schemmer P; Büchler MW; Salnikov AV; Herr I
    Gut; 2009 Jul; 58(7):949-63. PubMed ID: 18829980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.
    Ottinger S; Klöppel A; Rausch V; Liu L; Kallifatidis G; Gross W; Gebhard MM; Brümmer F; Herr I
    Int J Cancer; 2012 Apr; 130(7):1671-81. PubMed ID: 21544815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
    Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.
    López-Fauqued M; Gil R; Grueso J; Hernandez-Losa J; Pujol A; Moliné T; Recio JA
    Int J Cancer; 2010 Apr; 126(7):1549-61. PubMed ID: 19810100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.
    Lian J; Ni Z; Dai X; Su C; Smith AR; Xu L; He F
    Mol Cancer Ther; 2012 Feb; 11(2):416-26. PubMed ID: 22188816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
    Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
    J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
    Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
    PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.
    Augustine CK; Toshimitsu H; Jung SH; Zipfel PA; Yoo JS; Yoshimoto Y; Selim MA; Burchette J; Beasley GM; McMahon N; Padussis J; Pruitt SK; Ali-Osman F; Tyler DS
    Mol Cancer Ther; 2010 Jul; 9(7):2090-101. PubMed ID: 20571072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells.
    Upadhyaya B; Liu Y; Dey M
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
    Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
    Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.